Related Experiment Video

Updated: Aug 21, 2026

Spontaneous and Evoked Measures of Pain in Murine Models of Monoarticular Knee Pain
08:03

Spontaneous and Evoked Measures of Pain in Murine Models of Monoarticular Knee Pain

Published on: February 22, 2019

What can chronic arthritis pain teach about developing new analgesic drugs?

James Witter1, Raymond A Dionne

  • 1Center for Drug Evaluation & Research (CDER), FDA, Rockville, Maryland, USA.

Arthritis Research & Therapy
|November 13, 2004
PubMed

Insights

Chronic pain management needs better treatments beyond opioids and NSAIDs. Future strategies must consider genetic factors and individual responses for effective pain relief.

Area of Science:

  • Pain research
  • Pharmacology
  • Public health

Background:

  • Chronic pain presents a significant public health challenge with substantial economic impact.
  • Current pain management relies heavily on opioids and non-steroidal anti-inflammatory drugs (NSAIDs), highlighting a therapeutic gap.
  • A need exists for improved pain treatments stemming from a lack of translation of scientific knowledge.

Discussion:

  • Re-evaluating drug screening methods is crucial for discovering novel analgesics.
  • Recognizing the role of acute molecular-genetic events in the development of chronic pain is essential.
  • Validating analgesic targets within specific patient populations is necessary for treatment efficacy.

Key Insights:

  • Individual genetic profiles significantly influence pain perception and treatment response.
  • Incorporating measures of individual response into clinical trials will enhance outcome capture.
  • Translating molecular-genetic insights into clinical practice is key to advancing pain management.

Outlook:

  • Future pain management strategies should embrace personalized medicine approaches.
  • Developing novel therapeutic targets based on genetic variability could revolutionize pain treatment.
  • Improved clinical trial designs focusing on individual responses will accelerate the development of effective pain therapies.

More Related Videos

Development of Recombinant Proteins to Treat Chronic Pain10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...